Already have an account?


Login with an existing Projects In Knowledge account
New to Projects In Knowledge?


Register today to customize your experience.
Log In
Don't have an account yet? Click here to register



Register for Free
Already have an account? Click here to log in



Enter your current email address.  Your email address will be your user name, and where you will receive confirmation of this registration.



Forgot Password

Please Enter your email address.




  Terms & Conditions                                                                                                                                     

Privacy Policy

Projects In Knowledge is committed to protecting the privacy and confidentiality of visitors to our Web site. While Projects In Knowledge does not require that you provide us with personally identifiable information in order to visit our Web site, please note that in order to participate in the continuing medical education activities that we provide, it will be necessary for you to register with us and provide this information.

About this Privacy Policy
www.projectsinknowledge.com is our Web site for physicians and allied health care professionals, although it is open to non-professionals as well. The purpose of projectsinknowledge.com is to provide continuing medical education for healthcare professionals, and is intended for use only by a licensed healthcare professional.

Projects In Knowledge is the name we use to refer to our entire company, even though our formal corporate name is Projects In Knowledge, Inc. When we refer to ourselves as "we" or "Projects In Knowledge," we mean our company, Projects In Knowledge, Inc., including any subsidiary that we control (for example, a subsidiary that we own). We may share information among our subsidiaries that we own or control, but it is always protected under the terms of this privacy policy.

This privacy policy applies only to the Projects In Knowledge Web site. You should read the privacy policy at each Web site that you visit after you leave our site. We are not responsible for how other Web sites treat your privacy, once you leave the Projects In Knowledge site.

Privacy Policy Changes
If we change our privacy policy, we will post those changes on this page. Users should check this policy to keep abreast of any changes.

Information We Collect
In this section of our privacy policy, we discuss the different types of information we may collect about you, and the ways in which we collect them.

Information We Collect from Unregistered Visitors
Visitors to our Web site can access the Web site's home page and browse the site without disclosing any personally identifiable information. We do track information provided to us by your browser, including the Web site you came from (known as the "referring URL"), the type of browser you use, the time and date of access, and other information that does not personally identify you.

Information We Collect When You Register
Customers registering on our Web site for continuing medical education activities we provide are asked to provide us with identifying information, such as name, contact information, and other identifying information. On our registration screens, we clearly label which information is required for registration, and which information is optional and may be given at your discretion.

On our registration screens you will also find a “Burning Question” field. Submission of a “Burning Question” is completely voluntary. By submitting a “Burning Question,” you grant Projects In Knowledge the right to share it with faculty to consider as they prepare their continuing medical education presentations.

Listserves
When you are using a listserve—or member-only discussion board— on our Web site, you are posting a message and your user name, which is available for all registered members to see. You should not post any information to our listserves you want to keep private. It is a condition of our Web site that when participating in a listserve, you do not:

  • Restrict or inhibit any other user from using the listserve
  • Post or transmit any unlawful, threatening, abusive, libelous, defamatory, obscene, vulgar, pornographic, profane or indecent information of any kind, including, without limitation, any transmission constituting or encouraging conduct that would constitute a criminal offense, give rise to civil liability or otherwise violate any local, state, national or foreign law
  • Post or transmit any information, software or other material which violates or infringes upon the rights of others, including material which constitutes an invasion of privacy or infringement of publicity rights or which is protected by copyright, trademark or other proprietary right, or derivative works thereof, without first obtaining permission from the owner or right holder
  • Post or transmit any information, software or other material which contains a virus or other harmful component
  • Post, or transmit, or in any way exploit any information, software or other material for commercial purposes which contains advertising, promotions or marketing

By sending a message through the listserve, you grant Projects In Knowledge the non-exclusive right and license to display, copy, publish, distribute, transmit, print, and use such information. Projects In Knowledge reserves the right to terminate your access to, and use of, the listserve if you do not abide by these conditions.

Use of Cookies
Cookies are a technology used by the Projects In Knowledge Web site to identify a user as the user moves through the Web site. Your browser allows us to place some information on your computer's hard drive that identifies the computer you are using. We use cookies to track your usage throughout our Web site.

Your Web browser can be set to allow you to control whether you will accept cookies, reject cookies, or to notify you each time a cookie is sent to you. If your browser is set to reject cookies, Web sites that are cookie-enabled will not recognize you when you return to the Web site, and some Web site functionality may be lost. The Help section of your browser will tell you how to prevent your browser from accepting cookies.

Although cookies do not normally contain personally identifiable information, if you are a registered user we may associate your registration information with cookies our Web site places on your computer's hard drive. Associating a cookie with your registration data allows us to offer increased personalization and functionality. For example, you can elect to have our Web site "remember" you and bypass the registration process each time you register for one of our educational activities. Without cookies, this functionality would not be possible. Projects In Knowledge does not currently employ cookies for this use, but is considering it to make our registration processes more efficient for you.

Children's Privacy
Projects In Knowledge's Web site is designed and intended for use by adults, and is not intended for, nor designed to be used by children under the age of 18, or any other unlicensed, untrained individuals. We do not collect personally identifiable information from any person we know is a child under the age of 18.

Uses We Make of Information
In this section of our privacy policy, we identify the ways we may use information about you that we have collected.

Aggregate Data
We create aggregate data about visitors to our Web site for activity development and improvement. We also use it for market analysis. We may provide information from our Web site in aggregate form, with identifying information removed, to third parties. For example, we may tell a third party what percentage of our registered users reside in a particular geographical area. When aggregated information is provided, we pool it from many individual records and strip it of any data that could be used to identify an individual before it is used. Any third party that receives aggregated data must agree not to attempt to re-identify the people it belongs to. Projects In Knowledge does not sell any user data to any third party for commercial purposes.

Third Parties
In addition to aggregate information (discussed previously), we may share some kinds of information with third parties as described below.

  • Business Transfers: If we transfer a business unit (such as a subsidiary) or an asset (such as a Web site) to another company, we will require them to honor the applicable terms of this privacy policy.

Protection of Information
In this section of our privacy policy, we discuss the security measures we take to protect information that we have collected about you.

General Policies
We have implemented technology and security policies, rules and other measures to protect the personal data that we have under our control from unauthorized access, improper use, alteration, unlawful or accidental destruction, and accidental loss. We also protect your information by requiring that all our employees and others who have access to or are associated with the processing of your data respect your confidentiality. In addition, we have appropriate security measures in place in our physical facilities to protect against the loss or misuse of information at our site that we have collected from you.

Projects In Knowledge Employees
Projects In Knowledge employees are required to keep customer information private, as a condition of their employment with the company. Only selected, authorized Projects In Knowledge employees are permitted to access your registration information.
Employees are required to sign a confidentiality agreement. All employees and contractors must abide by our privacy policy, and those who violate that policy are subject to disciplinary action, up to and including termination of their employment and legal action.

Privacy Questions or Concerns about Our Web Site
For privacy questions or concerns about the Projects In Knowledge Web site, please contact privacy@projectsinknowledge.com.

Revision date: This policy was last updated on September 30, 2003.



New and Noteworthy
Education Initiative in Cardiology

  • Stroke Prevention — Journal Insights Into: Concomitant Use of Antiplatelet Therapy with Dabigatran or Warfarin in the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY®) Trial – Journal Insights
  • In the United States, it is estimated that nearly 800,000 patients with atrial fibrillation (AF) are on concomitant oral anticoagulation therapy (OAC) and antiplatelet therapy. Unfortunately, there is a great deal of uncertainty as to how to best manage these patients, with the majority of available data ... more >>
    J. Halperin, MD
  • Stroke Prevention — Importance of Bleeding in the New Era of Oral Anticoagulation for Stroke Prevention in Atrial Fibrillation – Webcast
  • Oral anticoagulant (OAC) drugs are highly effective for reducing stroke and systemic embolism in patients with atrial fibrillation (AF). However, bleeding remains the most common complication of OAC therapy and concerns over the risk of intracranial hemorrhage – the most feared complication – have led to ... more >>
    S. Connolly, MD, FRCPC
  • Stroke Prevention — Case Study: Periprocedural Anticoagulation Management in a Patient with Atrial Fibrillation Undergoing Colonoscopy: Challenges and New Opportunities – Tx Reporter e-Newsletter
  • The periprocedural management of patients on anticoagulation is common, yet challenging. Clinicians are faced with balancing myriad factors to determine optimal management strategies that mitigate both risk of thromboembolism and bleeding. Consideration of these factors determines if, how, and when treatment ... more >>
    J. Eikelboom, MBBS, MSc
  • Stroke Prevention — Case Study: A Patient with New Onset AF: To Anticoagulate or Not to Anticoagulate – Tx Reporter e-Newsletter
  • Managing a patient with atrial fibrillation (AF) entails three primary, though not mutually exclusive, objectives: control of ventricular rate, prevention of thromboembolism, and correction of the rhythm disturbance. Selection of thromboprophylaxis therapy for stroke prevention in patients at moderate risk ... more >>
    J. Halperin, MD
  • Stroke Prevention — Stroke Prevention in Atrial Fibrillation: The Advanced Curriculum – Curriculum
  • Atrial fibrillation (AF) is the most common form of arrhythmia and one of the leading causes of thromboembolic stroke. Because its prevalence increases with age, it is estimated that more than 6 million individuals will be affected with AF by 2050. It is critical that cardiologists and other clinicians are ... more >>
    S. Connolly, MD, FRCPC
  • Stroke Prevention — Journal Insights Into: Role of Oral Anticoagulant Therapy for Stroke Prevention in Concomitant AF and Renal Impairment – Journal Insights
  • Atrial fibrillation (AF) is common in patients with renal dysfunction and these patients are at high risk for stroke, as well as bleeding. Stroke prevention with oral anticoagulant therapy in patients with Atrial Fibrillation and renal impairment, therefore, presents unique challenges to the clinician in ... more >>
    J. Eikelboom, MBBS, MSc
  • Acute Coronary Syndrome — Case Study: Anticoagulation Therapy—Considerations in Patients Anticipating Surgery – Tx Reporter e-Newsletter
  • Stuart J. Connolly, MD, presents the case of a 78-year-old patient with non-valvular atrial fibrillation who is currently receiving anticoagulant therapy and will be undergoing elective surgery. Through this case, Dr. Connolly discusses perioperative anticoagulation strategies to balance the competing risks ... more >>
    S. Connolly, MD, FRCPC
  • Acute Coronary Syndrome — Expert Insight Into: The ARISTOTLE Trial—A Randomized Comparison of Anticoagulation Therapy with Factor Xa Inhibition Versus Vitamin K Inhibition in Patients with Atrial Fibrillation at Increased Risk for Stroke (Part 6 of Series) – Article Review
  • The ARISTOTLE (Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation) trial compared anticoagulation therapy with apixaban, a factor Xa inhibitor, to warfarin, a vitamin K antagonist, in patients with atrial fibrillation who had at least one additional risk factor for stroke. ... more >>
    S. Connolly, MD, FRCPC
  • Acute Coronary Syndrome — Case Study: Managing Stroke Risk in a Patient with Atrial Fibrillation and a Contraindication to Warfarin Anticoagulation – Tx Reporter e-Newsletter
  • Contraindications to anticoagulation are common among elderly patients with atrial fibrillation. The “ideal” candidate for anticoagulation is the exception rather than the rule. In this case-based TxReporter, Robert G. Hart, MD, presents a complex case and models how to make challenging risk-versus-benefit ... more >>
    S. Connolly, MD, FRCPC
  • Acute Coronary Syndrome — Management of Patients with Atrial Fibrillation at Increased Risk for Stroke: Current Strategies and Novel Treatments on the Horizon – Webcast
  • Atrial fibrillation (AF), the most common significant arrhythmia, increases the rate of stroke 5-fold. Warfarin has proven effective in preventing stroke in patients with AF, but its use is limited by a number of drawbacks, particularly an associated increase in the risk of intracranial bleeding. Recently, ... more >>
    S. Connolly, MD, FRCPC
  • Stroke Prevention in Atrial Fibrillation: The Advanced Curriculum
  • Atrial fibrillation (AF) is the most common form of arrhythmia and one of the leading causes of thromboembolic stroke. Because its prevalence increases with age, it is estimated that more than 6 million individuals will be affected with AF by 2050. It is critical that cardiologists and other clinicians are ... more >>
    S. Connolly, MD, FRCPC
  • The Advanced Curriculum Program: Stroke Prevention in Atrial Fibrillation
  • Atrial fibrillation (AF) is the most common form of arrhythmia and one of the leading causes of thromboembolic stroke. Because its prevalence increases with age, it is estimated that more than 6 million individuals will be affected with AF by 2050. It is critical that cardiologists and other clinicians are ... more >>
    S. Connolly, MD, FRCPC
  • Stroke Prevention — Case Study: Periprocedural Anticoagulation Management in a Patient with Atrial Fibrillation Undergoing Colonoscopy: Challenges and New Opportunities – Tx Reporter e-Newsletter
  • The periprocedural management of patients on anticoagulation is common, yet challenging. Clinicians are faced with balancing myriad factors to determine optimal management strategies that mitigate both risk of thromboembolism and bleeding. Consideration of these factors determines if, how, and when treatment ... more >>
    J. Eikelboom, MBBS, MSc
  • Stroke Prevention — Case Study: A Patient with New Onset AF: To Anticoagulate or Not to Anticoagulate – Tx Reporter e-Newsletter
  • Managing a patient with atrial fibrillation (AF) entails three primary, though not mutually exclusive, objectives: control of ventricular rate, prevention of thromboembolism, and correction of the rhythm disturbance. Selection of thromboprophylaxis therapy for stroke prevention in patients at moderate risk ... more >>
    J. Halperin, MD
  • Acute Coronary Syndrome — Case Study: Anticoagulation Therapy—Considerations in Patients Anticipating Surgery – Tx Reporter e-Newsletter
  • Stuart J. Connolly, MD, presents the case of a 78-year-old patient with non-valvular atrial fibrillation who is currently receiving anticoagulant therapy and will be undergoing elective surgery. Through this case, Dr. Connolly discusses perioperative anticoagulation strategies to balance the competing risks ... more >>
    S. Connolly, MD, FRCPC
  • Acute Coronary Syndrome — Case Study: Managing Stroke Risk in a Patient with Atrial Fibrillation and a Contraindication to Warfarin Anticoagulation – Tx Reporter e-Newsletter
  • Contraindications to anticoagulation are common among elderly patients with atrial fibrillation. The “ideal” candidate for anticoagulation is the exception rather than the rule. In this case-based TxReporter, Robert G. Hart, MD, presents a complex case and models how to make challenging risk-versus-benefit ... more >>
    S. Connolly, MD, FRCPC
  • Acute Coronary Syndrome — Case Study: Stroke Prevention in a Typical Patient with Atrial Fibrillation – Tx Reporter e-Newsletter
  • Daniel E. Singer, MD, presents the case of a 76-year-old patient with atrial fibrillation who is a candidate for electrical cardioversion. Through this case, Dr. Singer discusses the need for anticoagulation before and after cardioversion to prevent atrial thromboembolism, as well as criteria for assessing ... more >>
    S. Connolly, MD, FRCPC